LP-23

N/A

Report date: 2025/02/13 14:23:59
NME

Base Information

Drug NameLP-23
Drug Alias NameLP-23LP23
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgrammed death-ligand 1 blockersProgrammed cell death protein 1 blockers
TargetsProgrammed death-ligand 1Programmed cell death protein 1
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSouthern Medical University, China
China Registration ClassN/A

Develop Information

Active CompaniesSouthern Medical University, China
Inactive CompaniesN/A
Active IndicationsImmune System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A